A Case of Bortezomib-Associated Thrombotic Microangiopathy in a Multiple Myeloma Patient

Bortezomib is a first-generation proteasome inhibitor used in the treatment of multiple myeloma. We present a case of a 70-year-old woman with multiple myeloma, who presented thrombotic microangiopathy with multi-organ involvement thrombotic microangiopathy (ocular, cardiac, and renal) after bortezo...

ver descrição completa

Detalhes bibliográficos
Autor principal: Moreira Fonseca, N (author)
Outros Autores: Cardoso, F (author), Monteiro, M (author), Góis, M (author), Sousa, H (author), Fidalgo, T (author), Calado, J (author), Nolasco, F (author)
Formato: article
Idioma:eng
Publicado em: 2021
Assuntos:
HCC NEF
CHLC MED
Bortezomib
Thrombotic Microangiopathies
Multiple Myeloma
Toxicity
Texto completo:http://hdl.handle.net/10400.17/3867
País:Portugal
Oai:oai:repositorio.chlc.min-saude.pt:10400.17/3867

Texto Completo

http://hdl.handle.net/10400.17/3867

Registos relacionados